190117_Quidel社カタログ改訂【初校】.indd
|
|
|
- とよみ ままだ
- 5 years ago
- Views:
Transcription
1 RESEARCH KITS AND REAGENTS
2 Quidel MicroVue Immutopics MicroVue 50 ISO 13485:2003 ELISA Quidel Specialty Products is the option for all your research, biosafety and cytotoxicity testing needs.
3 Immutopics Fibroblast growth factor: FGF 23 D D FGF-23 PTH D FGF-23 PTH FGF-23 PTH Osteocalcin Human Mouse/Rat Canine FGF-23 (Intact) ELISA FGF-23 (C-Terminal) ELISA Bioactive PTH 1-84 ELISA PTH ELISA High Sensitive PTH 1-34 ELISA PTH (1-34) Antibody ELISA FGF-23 (Intact) ELISA FGF-23 (C-Terminal) ELISA Mouse PTH 1-84 ELISA Rat BioActive Intact-PTH ELISA Rat Intact PTH ELISA Mouse Osteocalcin ELISA Rat Osteocalcin ELISA Intact PTH ELISA FGF-23 PTH Osteocalcin ELISA ELISA Human Human FGF-23 (Intact) ELISA 1Kit ,000 Human FGF-23 (C-Terminal) ELISA 1Kit ,000 Human Bioactive PTH 1-84 ELISA 1Kit ,000 Human PTH ELISA 1Kit ,000 High Sensitive Human PTH 1-34 ELISA Mouse and Rat 1Kit ,000 Mouse/Rat FGF-23 (Intact) ELISA 1Kit ,000 Mouse FGF-23 (C-Terminal) ELISA 1Kit ,000 Mouse PTH 1-84 ELISA 1Kit ,000 Rat BioActive Intact-PTH ELISA 1Kit ,000 Rat Intact PTH ELISA 1Kit ,000 Mouse Osteocalcin ELISA 1Kit ,000 Rat Osteocalcin ELISA 1Kit ,000 Canine Canine Intact PTH ELISA 1Kit ,000 Rat PTH Sample Diluent 10ml ,000 Human PTH Sample Diluent 10ml ,000 Human FGF-23 Sample Diluent 10ml ,000
4 Bone Research to Rapids (BMD) (BAP) I (PICP, PINP) Quidel EIA MicroVue EIA EIA MicroVue Creatinine EIA 1Kit ,000 MicroVue Serum PYD EIA 1Kit ,000 MicroVue YKL-40 EIA 1Kit ,000 Human Sclerostin HS EIA 1Kit TE1023HS 231,000 Human Hyaluronic Acid Plus ELISA 1Kit TE ,000 EIA EIA CICP Controls - serum, set of 4 1Set ,000 Osteocalcin Controls - serum, set of 4 1Set ,000 BAP Controls - serum, set of 4 1Set ,000 YKL-40 Controls, set of 4 1Set ,000 DPD Controls - urine, set of 4 1Set ,000 Pyridinoline Controls - urine, set of 4 1Set ,000 Pyridinoline Controls - serum, set of 4 1Set ,000 Helical Peptide Controls - urine, set of 4 1Set ,000 Pyd/Dpd HPLC Calibrator 750µl ,000 HPLC Internal Setandard 5ml ,000 30k MWCO Spinfilters, 40/bag 1PK ,000
5 Bone EIA Human Intact Proinsulin ELISA 1Kit TE ,000 Mouse Anti-PINP #1 (9D9C4) 0.1ml ,000 Mouse Anti-PINP #2 ( 9G5A1) 0.1ml ,000 Mouse Anti-PINP #3 ( 7H10C6) 0.1ml ,000 Mouse Anti-PINP #4 (12C2C8) 0.1ml ,000 Mouse Anti-CICP antibody 0.1mg ,000 Mouse Anti-Dpd antibody 0.1mg ,000 Mouse Anti-Pyd antibody 0.1mg ,000 Mouse Anti-YKL-40 antibody 0.1mg ,000 Rabbit Anti-YKL-40 antibody 0.1mg ,000 Bovine H-Dpd 0.02mg ,000 Bovine H-Pyd 0.02mg ,000 Mouse YKL-40 Purified Protein 25µg A ,000
6 Complement Research to Rapids SLE EIA EIA MicroVue Ba Fragment EIA 1Kit A ,000 MicroVue Pan-Specific C3 Reagent Kit MicroVue C3a Plus EIA (For C3 activation) MicroVue ic3b EIA (For C3 activation) 1Kit ,000 1Kit A ,000 1Kit A ,000 MicroVue C4a Fragment EIA 1Kit A ,000 MicroVue C5a EIA 1Kit A ,000 MicroVue SC5b-9 Plus EIA (For MAC assembly, TCC, C5 and terminal pathway activation) 1Kit A ,000 MicroVue Factor H EIA 1Kit A ,000 Mouse C3a ELISA 1Kit TE ,000 Human Complement Protein, C1q 1ml A400 60,000 Human Complement Protein, C3 250µl A401 56,000 Human Complement Protein, C3a 250µl A414 56,000 Human Complement Protein, C3b 50µl A413 59,000 Human Complement Protein, C4 250µl A402 73,000 Human Complement Protein, C5 250µl A403 73,000 Human Complement Protein, SC5b-9 100µl A415 69,000 Human Complement Protein, C6 250µl A404 65,000 Human Complement Protein, C7 250µl A405 65,000 Human Complement Protein, C8 250µl A406 65,000 Human Complement Protein, C9 250µl A407 65,000 Human Complement Protein, Factor B 250µl A408 65,000 Human Complement Protein, Factor D 250µl A409 65,000 Human Complement Protein, Factor H 250µl A410 65,000 Human Complement Protein, Factor I 250µl A ,000 Human Complement Protein, Factor P 250µl A ,000 Human Complement Standard (normal human serum) 1ml A100 28,000 Normal Human Serum Complement 2.5ml A112 45,000 Normal Human Serum Complement 5ml A113 78,000 Complement Activator (heat aggregated gamma globulin) 0.2ml A114 88,000 Guinea Pig Serum Complement 5ml A119 49,000 Guinea Pig Serum Complement 2ml A121 22,000
7 Complement C1q Depleted Sera 1ml A509 37,000 C2 Depleted Sera 1ml A500 37,000 C3 Depleted Sera 1ml A508 60,000 C3/C4 Depleted Sera 1ml A521 44,000 C4 Depleted Sera 1ml A522 44,000 C4 Deficient Sera (Guinea Pig) 1ml A507 44,000 C5 Depleted Sera 1ml A501 37,000 C6 Depleted Sera 1ml A502 44,000 C7 Depleted Sera 1ml A503 44,000 C8 Depleted Sera 1ml A504 44,000 C9 Depleted Sera 1ml A505 44,000 Factor B Depleted Sera 1ml A506 44,000 Factor H Depleted Sera 1ml A523 65,000 Factor I Depleted Sera 1ml A524 60,000 Factor P Depleted Sera 1ml A512 44,000 Polyclonal, Anti-human C1-lnhibitor 2ml A300 44,000 Polyclonal, Anti-human C1q 2ml A301 44,000 Polyclonal, Anti-human C1s 2ml A302 44,000 Polyclonal, Anti-human C2 (Ig Fraction) 1ml A303 44,000 Polyclonal, Anti-human C3 2ml A304 44,000 Polyclonal, Anti-human C4 2ml A305 44,000 Polyclonal, Anti-human C5 2ml A306 44,000 Polyclonal, Anti-human C6 2ml A307 52,000 Polyclonal, Anti-human C7 2ml A308 52,000 Polyclonal, Anti-human C8 2ml A309 52,000 Polyclonal, Anti-human C9 2ml A310 44,000 Polyclonal, Anti-human Factor B 2ml A311 44,000 Polyclonal, Anti-human Factor H 2ml A312 44,000 Polyclonal, Anti-human Factor I 2ml A313 44,000 MoAb, Anti-human Bb (neoantigen) 100µl A252 60,000 MoAb, Anti-human Clusterin (SP40, 40 andapo J) 100µl A241 60,000 MoAb, Anti-human C1q 100µl A201 60,000 MoAb, Anti-human C3a 100µl A203 60,000 MoAb, Anti-human C3 (C3c) 100µl A205 60,000 MoAb, Anti-human C3 (C3d) 100µl A207 60,000 MoAb, Anti-human C3d (neoantigen) 100µl A250 60,000 MoAb, Anti-human ic3b (neoantigen) 100µl A209 80,000 MoAb, Anti-human C4 (C4c) 100µl A211 60,000 MoAb, Anti-human C4 (C4d) 100µl A213 63,000 MoAb, Anti-human C4 (C4d) 0.5ml A ,000 MoAb, Anti-human C4 binding protein 100µl A215 60,000 MoAb, Anti-human C4d (neoantigen) 100µl A251 60,000 MoAb, Anti-human C5 100µl A217 60,000 MoAb, Anti-human SC5b-9 (TCC neoantigen) 100µl A239 80,000 MoAb, Anti-human C6 100µl A219 60,000 MoAb, Anti-human C7 100µl A221 60,000 MoAb, Anti-human C8 100µl A249 60,000 MoAb, Anti-human C9 100µl A223 60,000 MoAb, Anti-human Factor B (Ba) 100µl A225 60,000 MoAb, Anti-human Factor B (Bb) 100µl A227 60,000 MoAb, Anti-human Factor H#1 100µl A229 60,000 MoAb, Anti-human Factor H#2 100µl A254 60,000 MoAb, Anti-human Factor H#3 100µl A255 60,000 MoAb, Anti-human Factor I#1 100µl A247 60,000 MoAb, Anti-human Factor I#2 100µl A231 60,000 MoAb, Anti-human Factor P#1 100µl A233 60,000 MoAb, Anti-human Factor P#2 100µl A235 60,000 MoAb, Anti-human S-Protein (vitronectin) 100µl A237 60,000 Biotinylated MoAb, Anti-human C1q 250µl A700 64,000 Biotinylated MoAb, Anti-human ic3b (neoantigen) 250µl A710 69,000 Biotinylated MoAb, Anti-human C3c 250µl A701 64,000 Biotinylated MoAb, Anti-human C3d 250µl A702 64,000 Biotinylated MoAb, Anti-human C4c 250µl A703 64,000 Biotinylated MoAb, Anti-human C4d 250µl A704 67,000 Biotinylated MoAb, Anti-human C5 250µl A705 64,000 Biotinylated MoAb, Anti-human SC5b-9 (neoantigen) 250µl A711 69,000 Biotinylated MoAb, Anti-human C6 250µl A706 64,000 Biotinylated MoAb, Anti-human C7 250µl A707 64,000 Biotinylated MoAb, Anti-human C8 250µl A708 64,000 Biotinylated MoAb, Anti-human C9 250µl A709 64,000 Biotinylated MoAb, Anti-human Factor B (Bb) 250µl A712 64,000
8 IWAI CHEMICALS COMPANY TEL FAX TEL FAX TEL FAX TEL TEL TEL TEL TEL TEL FAX
エピトープタグ抗体製品リスト PM020 Anti-DDDDK-tag pab Polyclonal Rabbit Ig (aff.) WB, IP, IC 100 ml 15,000 PM020-7 Anti-DDDDK-tag pab HRP-DirecT Polyclonal Rabbit I
(kda) 150 100 DDDDK-tagged protein 75 50 37 IgG Heavy chain 25 20 IgG Light chain Sample: N-terminal DDDDK-tagged β-gal protein transfectant μ μ μ http://ruo.mbl.co.jp/ エピトープタグ抗体製品リスト PM020 Anti-DDDDK-tag
DiovNT
Peptide Antisera and Monoclonal Antibodies (2) Antisera of Yanaihara Institute Inc. Monoclonal Antibodies Peptide Antisera and Antisera of Yanaihara Institute Inc. 274 Manufacturer: YANAIHARA INSTITUTE
1009.\1.\4.ai
- 1 - E O O O O O O - 2 - E O O O - 3 - O N N N N N N N N N N N N N N N N N N N N N N N E e N N N N N N N N N N N N N N N N N N N N N N N D O O O - 4 - O O O O O O O O N N N N N N N N N N N N N N N N N
ROWCatPathology_J.book
www.dako.jp IHC Solution Visualization Systems Number of Steps 5 4 3 2 1 LSAB TM 2 EnVision TM G 2 Doublestain EnVision TM DuoFLEX Doublestain LSAB TM + EnVision TM G 2 EnVision TM + EnVision TM FLEX 1
c a a ca c c% c11 c12
c a a ca c c% c11 c12 % s & % c13 c14 cc c16 c15 %s & % c211 c21% c212 c21% c213 c21% c214 c21% c215 c21% c216 c21% c23 & % c24 c25 c311 c311 % c% c % c312 %% a c31 c315 c32 c33 c34 % c35 c36 c411 c N
1007.\1.ai
- 1 - B - 2 - e - 3 - F O f g e f - 4 - O O N N N N N N N N N N N N N N N N N N N N N N N F C - 5 - N N N N N N N N N N N N N N N N N N N N N N N F - 6 - D - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 -
PrmryCellCltrガイド_0620.indd
初代細胞培養製品ガイド HEK HEKa C-005-5C [1Vial (>500k cells)] HEKa-APF C-021-5C [1Vial (>500k cells)] Epilife in vitro 2 Epilife 60µM CaCl 2 HEKn C-001-5C [1Vial (>500k cells)] HEKn-APF C-020-5C [1Vial (>500k cells)]
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 81
9 CQ 1 80 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 81 CQ 2 82 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 83 84 CQ 3 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 85 CQ 4
Immune checkpoint - CTLA-4 PD-1 2
CTLA-4 / PD-1 / PD-L1 Immune checkpoint - CTLA-4 PD-1 2 ACRO Biosystems ACRO Biosystems HEK293 Human PD-1 / PDCD1 Protein, Tag Free, Full Length PD-1 PD-1 ECD ACRO Biosystems 7 PD-1 PD-1 PD-1 His PD-1
EP760取扱説明書
D D D # % ' ) * +, B - B / 1 Q&A B 2 B 5 B 6 Q & A 7 8 $ % & ' B B B ( B B B B B B B B B B B ) B B B A # $ A B B * 1 2 # $ % # B B % $ # $ % + B B 1 B 2 B B B B B B B B B B , B B B - 1 3 2 2 B B B B B
d-00
283-0105 298 TEL. 0475-76-0839 FAX. 0475-76-0838 400g 300 4950399167708 14 220g 300 4950399066780 Page 1 300g 200 4950399066766 100 400g 300 4950399167722 350g 160 4950399066735 100 600g 350 4950399167685
( ) 2003 15 5 1 2007 19 4 30 2003 15 5 1 2007 19 4 30 2001 13 5 20 2005 17 5 19 2007 19 4 2011 23 4 No 1 2 3 4 5 6 1 2 3 1 2, 3 4 5 6 7 No 1 1 1 1 1 1 No A 1 22,847 A 1 8,449 15 B 5,349,170 C 5,562,167
c a a ca c c% c11 c12 % s & %
c a a ca c c% c11 c12 % s & % c13 c14 cc c15 %s & % c16 c211 c21% c212 c21% c213 c21% c214 c21% c215 c21% c216 c21% c23 & & % c24 c25 c311 c312 % c31 c315 c32 c33 c34 % c35 c36 c37 c411 c N N c413 c c414c
<8DD AA97A3834C B BF8A69838A C8EA E786C7378>
ST-01738 ErythroClear Red Blood Cell Depletion Reagent kit 臍帯血 2 ml 用 17,000 13,600 ST-01739 ErythroClear Red Blood Cell Depletion kit 臍帯血 2 ml 用 475,000 380,000 ST-07801 Lymphoprep 250 ml 17,000 13,600
取扱説明書 -詳細版- 液晶プロジェクター CP-AW3019WNJ
B A C D E F K I M L J H G N O Q P Y CB/PB CR/PR COMPONENT VIDEO OUT RS-232C LAN RS-232C LAN LAN BE EF 03 06 00 2A D3 01 00 00 60 00 00 BE EF 03 06 00 BA D2 01 00 00 60 01 00 BE EF 03 06 00 19 D3 02 00
BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mouse IgG , ,000 BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mous
Bio X Cell 社価格表 (2018 年 4 月 ) < 株式会社シン コーポレーション > Bio X Cell 社価格表 (2018 年 4 月 ) ご注文ごとに別途取扱手数料 (2( 万円 税別 ) を申し受けます 大学向け価格でのご購入には アカデミックプライス適用申込書のご提出が必須となります 品番クローン品名イソタイプ 容量 (mg) 大学向希望小売価格 ( 円 ) 税別 希望小売価格
2 3
Sample 2 3 4 5 6 7 8 9 3 18 24 32 34 40 45 55 63 70 77 82 96 118 121 123 131 143 149 158 167 173 187 192 204 217 224 231 17 285 290 292 1 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38
広報さっぽろ 2016年8月号 厚別区
8/119/10 P 2016 8 11 12 P4 P6 P6 P7 13 P4 14 15 P8 16 P6 17 18 19 20 P4 21 P4 22 P7 23 P6 P7 24 25 26 P4 P4 P6 27 P4 P7 28 P6 29 30 P4 P5 31 P5 P6 2016 9 1 2 3 P4 4 P4 5 P5 6 7 8 P4 9 10 P4 1 b 2 b 3 b
2 7 ( ) µ Ab-Match Assembly Human PAP1 (REG3a) Kit
CODE No. 323 For Research Use Only, Not for use in diagnostic procedures. Ab-Match Assembly Human PAP1 (REG3α) Kit For technical material or related information, please refer to http://ruo.mbl.co.jp/product/abmatch/abmatch.html.
日本組織適合性学会誌第20巻2号
Major Histocompatibility Complex 2013; 20 (2): 121 129 平成 25 年度認定 HLA 検査技術者講習会テキスト HLA 1) 1) HLA HLA HLA PRA Panel reactive antibody DSA Donor specific alloantibody class subclass non-hla HLA キーワード :Human
損保ジャパンの現状2011
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 62 63 64 65 66 67 68 69
Microsoft Word - 表紙資料２－４
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
< A F BF8A69955C8DEC90AC8D5291CC506C CB3967B292E786C7378>
輸 / 販売元 110-0008 東京都台東区池之端 2-9-1 エッジ ビル 本社 179-0073 東京都練 区 柄 3-14-17 E-mail info@digital-biology.co.jp URL http://www.digital-biology.co.jp 製造元 BioLegend 社 /BioLegend URL http:// http://www.biolegend.com/
untitled
-- -- -3- % % % 6% % % 9 66 95 96 35 9 6 6 9 9 5 77 6 6 5 3 9 5 9 9 55 6 5 9 5 59 () 3 5 6 7 5 7 5 5 6 6 7 77 69 39 3 6 3 7 % % % 6% % % (: ) 6 65 79 7 3 36 33 9 9 5 6 7 3 5 3 -- 3 5 6 76 7 77 3 9 6 5
untitled
NO. 2007 10 10 34 10 10 0570-058-669 http://www.i-nouryoku.com/index.html (40 ) () 1 NO. 2007 10 10 2.2 2.2 130 70 20 80 30 () () 9 10 () 78 8 9 () 2 NO. 2007 10 10 4 7 3 NO. 2007 10 10 40 20 50 2 4 NO.
橡matufw
3 10 25 3 18 42 1 2 6 2001 8 22 3 03 36 3 4 A 2002 2001 1 1 2014 28 26 5 9 1990 2000 2000 12 2000 12 12 12 1999 88 5 2014 60 57 1996 30 25 205 0 4 120 1,5 A 1995 3 1990 30 6 2000 2004 2000 6 7 2001 5 2002
O
11 2 1 2 1 1 2 1 80 2 160 3 4 17 257 1 2 1 2 3 3 1 2 138 1 1 170 O 3 5 1 5 6 139 1 A 5 2.5 A 1 A 1 1 3 20 5 A 81 87 67 A 140 11 12 2 1 1 1 12 22 1 10 1 13 A 2 3 2 6 1 B 2 B B B 1 2 B 100 B 10 B 3 3 B 1
......1201-P1.`5
2009. No356 2/ 5 6 a b b 7 d d 6 ca b dd a c b b d d c c a c b - a b G A bb - c a - d b c b c c d b F F G & 7 B C C E D B C F C B E B a ca b b c c d d c c d b c c d b c c d b d d d d - d d d b b c c b
![かんたん操作ガイド[arrows M02]](/thumbs/39/20071242.jpg "かんたん操作ガイド[arrows M02]")
![かんたん操作ガイド[arrows RM02]](/thumbs/39/20475147.jpg "かんたん操作ガイド[arrows RM02]")
![かんたん操作ガイド[arrows M03]](/thumbs/42/22941141.jpg "かんたん操作ガイド[arrows M03]")
untitled
351 351 351 351 13.0 0.0 25.8 1.0 0.0 6.3 92.9 0.0 80.5 0.0 1.5 15.9 0.0 3.5 13.1 0.0 30.0 54.8 18.0 0.0 27.5 1.0 0.0 2.5 94.7 0.0 91.7 0.0 1.3 14.7 0.0 3.8 14.4 0.0 25.0 50.5 16.0 0.0 27.5 2.0 0.0 2.5
[PDF] Typhoonカタログ
![[PDF] Typhoonカタログ](/thumbs/92/108545061.jpg "[PDF] Typhoonカタログ")
GE imagination at work www.gehealthcare.co.jp/lifesciences 71-1891-02 Typhoon Typhoon Molecular Dynamics 1989 PhosphorImager 1992 CLSM 1 View it all from your benchtop 2000 Gen III System 1998 MegaBACE
untitled
2010824 1 2 1031 5251020 101 3 0.04 % 2010.8.18 0.05 % 1 0.06 % 5 0.12 % 3 0.14 % 2010.8.16 5 0.42 % 2010.7.15 25 5 0.42 % 0.426% 2010.6.29 5 0.496 % 2010.8.12 4 0.85 % 2010.8.6 10 0.900 % 2010.8.18 2.340
JP.qxd
Agilent ZORBAX Eclipse Plus LC LC Our measure is your success. products applications software services PAH? ZORBAX Eclipse Plus Eclipse Plus LC (PAH) C18 ZORBAX Eclipse Plus ZORBAX 2 ZORBAX Eclipse Plus
第１章
. 23 % 16.52 0.2 17.4 34.63 0.5 36.6 43.56 0.6 46.0 3 94.71 1.2 100 558.69 7.2 7,779.55 100 13. 24 16.1 16.0 16.8 16.6 19.6 21.1 19.4 21.1 13.2 11.5 14.4 12.5 64 57 43 2,056.7 2,056.7 2,260.7 2,204.0 113
[A](2): [B](4): DNA [B] [B](4):
: [B](4): DNA [B] [B](4):](/thumbs/91/104797401.jpg "[A](2): [B](4): DNA [B] [B](4):")
3 [A](2): 7 6 19.4 16.7 [A] 0 0.0 1 2.8 1 2.8 13 [A](1): 36.1 1974 1 3.0 2 5.6 1975 1 3.0 2 5.6 1980 1 3.0 4 11.1 1990 1 3.0 0 0.0 1993 1 3.0 36 100.0 1994 1 3.0 1999 1 3.0 [A](2): 2000 1 3.0 2001 5 15.2
CHEMOTHERAPY Fig. 1 Chemical structure of TE-031
CHEMOTHERAPY Fig. 1 Chemical structure of TE-031 CHEMOTHERAPY Table 1 Experimental groups for active systemic anaphylaxis in guinea pigs : Single dosage Fig. 2 Schedule for active systemic anaphylaxis
RAA-05(201604)MRA対応製品ver6
M R A 対 応 製 品 ISO/IEC 17025 ISO/IEC 17025は 試験所及び校正機関が特定の試験又は 校正を実施する能力があるものとして認定を 受けようとする場合の一般要求事項を規定した国際規格 国際相互承認 MRA Mutual Recognition Arrangement 相互承認協定 とは 試験 検査を実施する試験所 検査機関を認定する国際組織として ILAC 国際試験所認定協力機構
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17-54 55 56 57 58 ( ) 54 7 55 56 57 58 10 54 55 57 58 56 25 27 25 27 20 22 25 22 1.4g 23 23 :1.8g
17. (1) 18. (1) 19. (1) 20. (1) 21. (1) (3) 22. (1) (3) 23. (1) (3) (1) (3) 25. (1) (3) 26. (1) 27. (1) (3) 28. (1) 29. (1) 2
1. (1) 2. 2 (1) 4. (1) 5. (1) 6. (1) 7. (1) 8. (1) 9. (1) 10. (1) 11. (1) 12. (1) 13. (1) 14. (1) 15. (1) (3) 16. (1) 1 17. (1) 18. (1) 19. (1) 20. (1) 21. (1) (3) 22. (1) (3) 23. (1) (3) 24. 1 (1) (3)
() (1) (2) (1) 235 () 251 (1) 1,745 1,737 (2) 1,597
16 4 15 1 51 1 10 19912 1618 15[ ] 49,50016121 1612 15[ ] 16 1515 16 15[ ] 1111 12 1613 16 4 15 2 11 199 1618 1511 1512241612 () (1) (2) (1) 235 () 251 (1) 1,745 1,737 (2) 1,597 16 4 15 3 363 (1) 203,600201,450
ガイドライン2004
GUIDELINE 2004 2004 1 1993 2000NIH 1) compromized bone strength bone mineral densitybmdbone quality 2,3) BMDBMD 4) 2 BMD DXA 5) 11(191) 6) QOL 3 BMD 7) 810) 11,12) 13) 1416) 2001 2004 4 2001 17) 2002 18)
QIAzol Lysis Reagent MaXtract High Density RNAlater RNA Stabilization Reagent QIAGEN QIAzol Lysis Reagent RNA RNase MaXtract High Density QIAzol QIAzo
Vol.7November 216 3 DNA QIAamp DNA Mini Kit QIAcube QIAamp DNA Mini Kit 2 M Lung Kidney Liver Skin and muscle Whole blood Buffy coat Lymphocytes M QIAcube DNA 48.5 kb QIAamp DNA Mini Kit (5) 5134 25, QIAamp
QW-3414
MA1312-C P 1 2 3 A E L D E D A A E D A D D D D D E A C A C E D A A A C A C A C E E E D D D A C A C A A A A C A C A C E E C C E D D C C C E C E C C E C C C E D A C A C A C E L B B
Ver.1.0.1-1512 1. 03 2. 04 3. 05 05 4. 06 07 5. 08 6. 09 10 11 12 14 7. 19 2 1. Plus / 3 2. 1 4 3. Plus 5 4. FX 6 4. 7 5. 1 200 3 8 6. 38 25 16 9 6. 10 6. 11 6. 38 / 12 6. 13 6. 25 14 6. 0 359 15 6. 3
TaKaRa Bradford Protein Assay Kit
研究用 TaKaRa Bradford Protein Assay Kit 説明書 v201701da TaKaRa Bradford Protein Assay Kit は Coomassie Dye を用いる Bradford 法に基づいたキットであり 簡単な操作で迅速に 濃度範囲が 1 ~ 1,000 μg/ml のタンパク質溶液の定量を行うことができます 本キットの定量の原理は Coomassie
(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..
... -1... -1... -2... -6.... -1 (1)... -1 1)... -1 2)... -14 (2)... -19 (3)... -52 (4)... -18 (5)... -136.... -196 (1)... -196 (2) b... -224 (3)... -233.... -251.... -286.... -289 (1)... -289 (2)... -32
1. 2001 10 2 480 2003 8 1.6 5 2. 90 3. 4. 5. 5 60 6. 1 2 2 2 4 5 5 6 6 6 7 10 10 10 12 12 12 14 14 15 15 60 15 17 17 18 2001 10 2 480 2003 8 1.6 5 1 1.8 3.6 1 6.8 1.5 3 3 5 6065 70 5 1.22004 1 1 2002 4
HITACHI 液晶プロジェクター CP-AX3505J/CP-AW3005J 取扱説明書 -詳細版- 【技術情報編】
B A C E D 1 3 5 7 9 11 13 15 17 19 2 4 6 8 10 12 14 16 18 H G I F J M N L K Y CB/PB CR/PR COMPONENT VIDEO OUT RS-232C LAN RS-232C LAN LAN BE EF 03 06 00 2A D3 01 00 00 60 00 00 BE EF 03 06 00 BA D2 01
DynalTransplantDiagnostic.indd
2011 1 SeCore HLA SBT 1 2 AllSet + Gold SSP HLA 7 3 SSP UniTray HLA 11 4 27 5 32 ii 1 SeCore HLA SBT SeCore 2 SeCore HLA SBT SeCore 3 SeCore 4 HLA-I 5 HLA-II 5 utype 5 GSSP 6 1 SeCore HLA SBT Sequencing
17 18 2
17 18 2 18 2 8 17 4 1 8 1 2 16 16 4 1 17 3 31 16 2 1 2 3 17 6 16 18 1 11 4 1 5 21 26 2 6 37 43 11 58 69 5 252 28 3 1 1 3 1 3 2 3 3 4 4 4 5 5 6 5 2 6 1 6 2 16 28 3 29 3 30 30 1 30 2 32 3 36 4 38 5 43 6
16 9 Paula TFC BMI PSL hydroxysteroid dehydrogenase (11 -HSD) modulator ( prereceptor mod
Glucocorticoid-Induced Bone Disease (Clinical Practice) NEJM, July 7, 2011 Robert S. Weinstein, M.D. NEJM July 7 2011 Clinical Practice Glucocorticoid-Induced Bone Disease Arcansas Robert S. Weinstein,
A, B 2 B 5 A C A ADP A G ADP ADP G camp B GM A B CTB Tochikubo et al., 1998 CTB CTB Dertzbaugh & Elson, 1993a; Yu et al., 1994; Shi et al., 1995 CTB C
2004 Analysis of the expression of cholera toxin B-subunit gene 1065010 2004 8 26 1 A, B 2 B 5 A C A ADP A G ADP ADP G camp B GM A B CTB Tochikubo et al., 1998 CTB CTB Dertzbaugh & Elson, 1993a; Yu et
おすすめのローディング コントロール抗体 ターゲット 免疫動物 * モノ M ポリ P 交差性 * 製品番号 Actin Rb P Ms, Rat, Chk, Cow, Hu, Xl,Dm, Zfsh ab1801 alpha sarcomeric Actin Ms M Hu, Ms, Rat ab
ローディング コントロール抗体 アブカムならあなたにぴったりの コントロール抗体 が見つかるはずです ローディング コントロール抗体 (Loading control antibody) は ウエスタン ブロッティングにおけるポジティブ コントロールとなる抗体で 各レーンのサンプルが均等に泳動されていることの確認 ゲルからメンブレンへ確実に転写されていることの確認 また異なるサンプル中のターゲット
‚å™J‚å−w“LŁñ›ÄP1-7_7/4
2006 167 FFFFFFFFF FFFFFFFFF 2 3 4 5 6 7 8 9 d ca 10 c f e 11 e g e 12 d b 13 f bf 14 15 16 17 b c d cc bc e ef gf gf dc dc bc f f cd bf e df bd f bf c C d E c e 18 19 bc b b f 20 d d e d e bf ec d e ef
untitled
...1... 3 1... 3 2... 4 3... 4 4... 5...... 6 1... 6 2... 7 3... 8 4... 9 5... 10... 12 1... 12 2... 13 3... 14 4... 16...... 19 1... 19 2... 20 3... 22 4... 24...... 25... 26 1... 26 2... 26 3... 26......
プロトコール集 ( 研究用試薬 ) < 目次 > 免疫組織染色手順 ( 前処理なし ) p2 免疫組織染色手順 ( マイクロウェーブ前処理 ) p3 免疫組織染色手順 ( オートクレーブ前処理 ) p4 免疫組織染色手順 ( トリプシン前処理 ) p5 免疫組織染色手順 ( ギ酸処理 ) p6 免疫
< 目次 > 免疫組織染色手順 ( 前処理なし ) p2 免疫組織染色手順 ( マイクロウェーブ前処理 ) p3 免疫組織染色手順 ( オートクレーブ前処理 ) p4 免疫組織染色手順 ( トリプシン前処理 ) p5 免疫組織染色手順 ( ギ酸処理 ) p6 免疫組織染色手順 ( ギ酸処理後 マイクロウェーブまたはオートクレーブ処理 )p7 抗原ペプチドによる抗体吸収試験 p8 ウエスタン ブロッティング
ŁaŠšfiÁ‘W“ƒDFflÅ
3. 298-21741 Weigert's Iron Hematoxylin Staining Set 1set 12,000 1 1% 96% 1 2% 0.25%, 1:1 233-01655 Weigert's Resorcin Fuchsin Solution 3,600 1g 2% 100ml 70% 400ml 2% 70% 221-01415 Van Gieson Solution
Introduction ur company has just started service to cut out sugar chains from protein and supply them to users by utilizing the handling technology of
Standard PA-Sugar Chain Catalogue Masuda Chemical Industries Co., LTD. http://www.mc-ind.co.jp Introduction ur company has just started service to cut out sugar chains from protein and supply them to users
取扱説明書 ［F-01F］
F-0F 3.0 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 9 20 a b c d a b c 2 d 22 a b cd e a b c d e 23 24 25 26 a b a b 27 28 b a 29 c d 30 r s t u v w x a b c e f g d h n i j k l m a b o c d p e f g h i j k q l
FINEPIX HS10 使用説明書／ソフトウェア取扱ガイド
BB21249-102 JA DIGITAL CAMERA FINEPIX HS10 http://fujifilm.jp/ 1 2 3 y y y y y y y 3 1 2 B SP1/SP2 M C P S A M EVF/LCD DISP/BACK M M BAUTO Adv. SP1 SP2 N P S A M C F N h c I J P B O d ISO A F a L P K
Amnis TM CellStream TM CellStream TM
Amnis TM CellStream TM CellStream TM Amnis TM CellStream TM Amnis TM CCD FITC PE 5 96 7 CFR Part FDA TM CellStream Luminex Time Delay Integration TDI CellStream. 7... CCD CellStream Amnis CCD CellStream
０４年度LS民法Ⅰ教材改訂版.PDF
?? A AB A B C AB A B A B A B A A B A 98 A B A B A B A B B A A B AB AB A B A BB A B A B A B A B A B A AB A B B A B AB A A C AB A C A A B A B B A B A B B A B A B B A B A B A B A B A B A B A B